Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standard vs Reduced Number of Intravesical BCG Instillations in High-Grade Non-Muscle Invasive Bladder Cancer
DRKS00005651Phase 3Terminated
- Sponsor
- European Association of Urology
- Start
- Jan 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
Phase 3, randomised trial of bcg vaccine in bladder cancer and transitional cell carcinoma of the bladder (TCC) (2 arms), sponsored by European Association of Urology. Started Jan 2014; status: terminated.
02
Drugs
bcg vaccine
03
Conditions
bladder cancertransitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on DRKS00005651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00005651.